Pearl powder reduces sleep disturbance stress response through regulating proteomics in a rat model of sleep deprivation.
Meng XiaDelun HuangYuangming TongJiang LinPublished in: Journal of cellular and molecular medicine (2020)
Morris water maze tests revealed improvements of insomnia-induced cognitive deficit in both PP- and ES-treated rats, as compared to SD rats. However, proteomic analysis indicates that the pharmacological impact on gene expression of these two medicines is quite different: pearl is more capable of correcting aberrant gene expression caused by SD than estazolam. Therefore, pearl is more suitable for treatment of insomnia. These data, together with protein-protein interaction analysis, indicate that several pathways, affected by sleep deprivation, may be rescued by pearl powder: retrograde endocannabinoid signalling pathway, and the protein interaction or network enrich in oxidative phosphorylation Parkinson's disease and Huntington disease, etc CONCLUSIONS: Sleep deprivation can mimic cognition decline caused by insomnia with altered protein expression in the hippocampus; such behavioural and pathological changes can be significantly ameliorated by pearl powder.
Keyphrases
- sleep quality
- gene expression
- protein protein
- physical activity
- dna methylation
- small molecule
- depressive symptoms
- mass spectrometry
- mild cognitive impairment
- diabetic rats
- high glucose
- electronic health record
- big data
- oxidative stress
- white matter
- blood brain barrier
- cognitive impairment
- label free
- artificial intelligence
- replacement therapy